{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T23:06:16Z","timestamp":1754262376245,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Support Fund at Hospital de Cli\u0301nicas de Porto Alegre"},{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education Personnel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The use of thiazide (T) diuretics for the treatment of hypertension may be associated with adverse metabolic effects, which can be minimized by combining thiazides with potassium-sparing (PS) diuretics. The additional blood pressure (BP)-lowering effect provided by the addition of a PS diuretic is unclear. Due to a large number of drugs in the T diuretics class, and the possible difference between them, there is a need to identify the best available evidence for health decision-making. This systematic review with network meta-analysis aims to compare the antihypertensive efficacy of T diuretics alone or in combination with a PS diuretic in patients with primary hypertension, as well as the safety of such drugs through the measurement of drug-related adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A comprehensive electronic search will be conducted in six electronic bibliographic databases (PubMed\/MEDLINE, Cochrane Library, Embase, Web of Science, Scopus, Lilacs), a registration database (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>), and Educational Resources Information Center (ERIC [ProQuest]), published from inception to the date of the search. The search will be updated towards the end of the review. A hand search of the reference sections of the included studies and cited studies will also be performed. In case of missing data, authors will be contacted by e-mail or academic social networking sites whenever possible. To be included in the review, studies must be double-blind randomized controlled trials evaluating T diuretics alone or in combination with PS diuretics in patients with primary hypertension. The primary outcome measure will be office BP. Ambulatory BP monitoring (ABPM), non-melanoma skin cancer, major adverse cardiovascular events, laboratory parameters, and the number of withdrawals will be included as secondary outcomes. The results will be quantitatively summarized using differences between the mean change from baseline or differences between means for quantitative outcomes and relative risk for dichotomous outcomes. Results will be presented as mean or relative risk with credible intervals through a league table. The treatments will also be ranked using the surface under the cumulative ranking curve method. The risk of bias will be assessed through the RoB 1.0 tool.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>To the best of our knowledge, this review will be the first to synthesize currently available evidence on the antihypertensive efficacy of different T diuretics alone or in combination with PS diuretics in adults with hypertension. The goals of hypertension treatment are to control high BP and to reduce associated cardiovascular morbidity and mortality, using the most appropriate therapy. Thiazides are widely used for pharmacological treatment due to their demonstrated effectiveness in reducing BP, favorable safety profile, and low cost. The results of this study will provide evidence regarding the best therapeutic strategies with T and PS diuretics, evidencing interventions with better antihypertensive efficacy and safety profile.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>This systematic review and network meta-analysis was prospectively registered at the PROSPERO database (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=118492\">CRD42018118492<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-022-01890-y","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T21:02:27Z","timestamp":1644354147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Thiazide diuretics alone or in combination with a potassium-sparing diuretic on blood pressure-lowering in patients with primary hypertension: protocol for a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1483-4335","authenticated-orcid":false,"given":"V\u00edtor M.","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia K.","family":"Ziegelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Helal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipe","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo B.","family":"Lucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra C.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio D.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"1890_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jama.1958.02990020025004","volume":"166","author":"ED Freis","year":"1958","unstructured":"Freis ED, Wanko A, Wilson IM, et al. Treatment of essential hypertension with chlorothiazide (Diuril): its use alone and combined with other antihypertensive agents. J Am Med Assoc. 1958;166:137\u201340.","journal-title":"J Am Med Assoc"},{"key":"1890_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0002-9149(59)90289-9","volume":"3","author":"M Moser","year":"1959","unstructured":"Moser M, Macaulay AI. Chlorothiazide as an adjunct in the treatment of essential hypertension. Am J Cardiol. 1959;3:214\u20139.","journal-title":"Am J Cardiol"},{"key":"1890_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/bmj.300.6730.975","volume":"300","author":"JE Carlsen","year":"1990","unstructured":"Carlsen JE, K\u00f8ber L, Torp-Pedersen C, et al. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ. 1990;300:975\u20138.","journal-title":"BMJ"},{"key":"1890_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/01.HYP.15.4.348","volume":"15","author":"BJ Materson","year":"1990","unstructured":"Materson BJ, Cushman WC, Goldstein G, et al. Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study. Hypertension. 1990;15:348\u201360.","journal-title":"Hypertension"},{"key":"1890_CR5","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","volume":"289","author":"BM Psaty","year":"2003","unstructured":"Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534\u201344.","journal-title":"JAMA"},{"key":"1890_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/bmj.309.6949.226","volume":"309","author":"R Harper","year":"1994","unstructured":"Harper R, Ennis CN, Sheridan B, et al. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. BMJ. 1994;309:226\u201330.","journal-title":"BMJ"},{"key":"1890_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/0002-9149(89)90255-5","volume":"63","author":"ED Freis","year":"1989","unstructured":"Freis ED, Thomas JR, Fisher SG, et al. Effects of reduction in drugs or dosage after long-term control of systemic hypertension. Am J Cardiol. 1989;63:702\u20138.","journal-title":"Am J Cardiol"},{"key":"1890_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/archinte.158.7.741","volume":"158","author":"PJ Savage","year":"1998","unstructured":"Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med. 1998;158:741\u201351.","journal-title":"Arch Intern Med"},{"key":"1890_CR9","first-page":"CD003824","volume":"5","author":"VM Musini","year":"2014","unstructured":"Musini VM, Nazer M, Bassett K, et al. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database Syst Rev. 2014;5:CD003824.","journal-title":"Cochrane Database Syst Rev"},{"key":"1890_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/HJH.0000000000000837","volume":"34","author":"FD Fuchs","year":"2016","unstructured":"Fuchs FD, Scala LC, Vilela-Martin JF, et al. Effectiveness of chlorthalidone\/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial. J Hypertens. 2016;34:798\u2013806.","journal-title":"J Hypertens"},{"key":"1890_CR11","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.","journal-title":"BMJ"},{"key":"1890_CR12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.114.05021","volume":"65","author":"GC Roush","year":"2015","unstructured":"Roush GC, Ernst ME, Kostis JB, et al. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension. 2015;65:1041\u20136.","journal-title":"Hypertension"},{"key":"1890_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.HYP.0000103632.19915.0E","volume":"43","author":"BL Carter","year":"2004","unstructured":"Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43:4\u20139.","journal-title":"Hypertension"},{"key":"1890_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","volume":"47","author":"ME Ernst","year":"2006","unstructured":"Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47:352\u20138.","journal-title":"Hypertension"},{"key":"1890_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.111.190637","volume":"59","author":"MA Peterzan","year":"2012","unstructured":"Peterzan MA, Hardy R, Chaturvedi N, et al. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension. 2012;59:1104\u20139.","journal-title":"Hypertension"},{"key":"1890_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jacc.2015.10.083","volume":"67","author":"AK Pareek","year":"2016","unstructured":"Pareek AK, Messerli FH, Chandurkar NB, et al. Efficacy of low-dose chlorthalidone and hydrochlorothiazide as assessed by 24-h ambulatory blood pressure monitoring. J Am Coll Cardiol. 2016;67:379\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"1890_CR17","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra0907219","volume":"361","author":"ME Ernst","year":"2009","unstructured":"Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med. 2009;361:2153\u201364.","journal-title":"N Engl J Med"},{"key":"1890_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.amjmed.2011.06.031","volume":"124","author":"AA Leung","year":"2011","unstructured":"Leung AA, Wright A, Pazo V, et al. Risk of thiazide-induced hyponatremia in patients with hypertension. Am J Med. 2011;124:1064\u201372.","journal-title":"Am J Med"},{"key":"1890_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jama.1992.03480080053026","volume":"267","author":"D Siegel","year":"1992","unstructured":"Siegel D, Hulley SB, Black DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992;267:1083\u20139.","journal-title":"JAMA"},{"key":"1890_CR20","doi-asserted-by":"publisher","first-page":"53S","DOI":"10.1016\/S0002-9343(96)00268-9","volume":"101","author":"JM Flack","year":"1996","unstructured":"Flack JM, Cushman WC. Evidence for the efficacy of low-dose diuretic monotherapy. Am J Med. 1996;101:53S\u201360S.","journal-title":"Am J Med"},{"key":"1890_CR21","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","volume":"330","author":"DS Siscovick","year":"1994","unstructured":"Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 1994;330:1852\u20137.","journal-title":"N Engl J Med"},{"key":"1890_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S2213-8587(15)00377-0","volume":"4","author":"MJ Brown","year":"2016","unstructured":"Brown MJ, Williams B, Morant SV, et al. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. Lancet Diabetes Endocrinol. 2016;4:136\u201347.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1890_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/14740338.2012.712109","volume":"11","author":"F Deepinder","year":"2012","unstructured":"Deepinder F, Braunstein GD. Drug-induced gynecomastia: an evidence-based review. Expert Opin Drug Saf. 2012;11:779\u201395.","journal-title":"Expert Opin Drug Saf"},{"key":"1890_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","volume":"41","author":"WB White","year":"2003","unstructured":"White WB, Duprez D, St Hillaire R, et al. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension. 2003;41:1021\u20136.","journal-title":"Hypertension"},{"key":"1890_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16:925\u201330.","journal-title":"Am J Hypertens"},{"key":"1890_CR26","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386:2059\u201368.","journal-title":"Lancet"},{"key":"1890_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/HYPERTENSIONAHA.117.10662","volume":"71","author":"EM Krieger","year":"2018","unstructured":"Krieger EM, Drager LF, Giorgi DMA, et al. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment). Hypertension. 2018;71:681\u201390.","journal-title":"Hypertension"},{"key":"1890_CR28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/HJH.0000000000001671","volume":"36","author":"G Bazoukis","year":"2018","unstructured":"Bazoukis G, Thomopoulos C, Tsioufis C. Effect of mineralocorticoid antagonists on blood pressure lowering: overview and meta-analysis of randomized controlled trials in hypertension. J Hypertens. 2018;36:987\u201394.","journal-title":"J Hypertens"},{"key":"1890_CR29","first-page":"CD008167","volume":"11","author":"BS Heran","year":"2012","unstructured":"Heran BS, Chen JM, Wang JJ, et al. Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension. Cochrane Database Syst Rev. 2012;11:CD008167.","journal-title":"Cochrane Database Syst Rev"},{"key":"1890_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","volume":"46","author":"C Saha","year":"2005","unstructured":"Saha C, Eckert GJ, Ambrosius WT, et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension. 2005;46:481\u20137.","journal-title":"Hypertension"},{"key":"1890_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","volume":"116","author":"SJ Hood","year":"2007","unstructured":"Hood SJ, Taylor KP, Ashby MJ, et al. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Circulation. 2007;116:268\u201375.","journal-title":"Circulation"},{"key":"1890_CR32","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981\u201397.","journal-title":"JAMA"},{"key":"1890_CR33","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887\u201398.","journal-title":"N Engl J Med"},{"key":"1890_CR34","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1161\/HYPERTENSIONAHA.111.183525","volume":"58","author":"NM Kaplan","year":"2011","unstructured":"Kaplan NM. Chlorthalidone versus hydrochlorothiazide: a tale of tortoises and a hare. Hypertension. 2011;58:994\u20135.","journal-title":"Hypertension"},{"key":"1890_CR35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.114.05122","volume":"65","author":"RH Olde Engberink","year":"2015","unstructured":"Olde Engberink RH, Frenkel WJ, van den Bogaard B, et al. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis. Hypertension. 2015;65:1033\u201340.","journal-title":"Hypertension"},{"key":"1890_CR36","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","volume":"59","author":"GC Roush","year":"2012","unstructured":"Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension. 2012;59:1110\u20137.","journal-title":"Hypertension"},{"key":"1890_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/HYPERTENSIONAHA.110.161505","volume":"57","author":"MP Dorsch","year":"2011","unstructured":"Dorsch MP, Gillespie BW, Erickson SR, et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. 2011;57:689\u201394.","journal-title":"Hypertension"},{"key":"1890_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.7326\/0003-4819-158-6-201303190-00004","volume":"158","author":"IA Dhalla","year":"2013","unstructured":"Dhalla IA, Gomes T, Yao Z, et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann Intern Med. 2013;158:447\u201355.","journal-title":"Ann Intern Med"},{"key":"1890_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.292.1.43-c","volume":"292","author":"BM Psaty","year":"2004","unstructured":"Psaty BM, Lumley T, Furberg CD. Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies. JAMA. 2004;292:43\u20134.","journal-title":"JAMA"},{"key":"1890_CR40","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","volume":"336","author":"F Turnbull","year":"2008","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration, Turnbull F, Neal B, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121\u20133.","journal-title":"BMJ"},{"key":"1890_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957\u201367.","journal-title":"Lancet"},{"key":"1890_CR42","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/HJH.0000000000001777","volume":"36","author":"C Thomopoulos","year":"2018","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis. J Hypertens. 2018;36:1637\u201347.","journal-title":"J Hypertens"},{"key":"1890_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"1890_CR44","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.","journal-title":"PLoS Med"},{"key":"1890_CR45","volume-title":"Thiazide diuretics alone or in combination with potassium-sparing diuretics on blood pressure lowering efficacy in patients with primary hypertension: a protocol systematic review and network meta-analysis [internet]","author":"VM Martins","year":"2018","unstructured":"Martins VM, Ferrari F, Lucca MB, et al. Thiazide diuretics alone or in combination with potassium-sparing diuretics on blood pressure lowering efficacy in patients with primary hypertension: a protocol systematic review and network meta-analysis [internet]., 2018. Available: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=118492 [Accessed 06 Sep 2020]."},{"key":"1890_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/01.CIR.23.2.200","volume":"23","author":"FC Reubi","year":"1961","unstructured":"Reubi FC, Cottier PT. Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation. 1961;23:200\u201310.","journal-title":"Circulation"},{"key":"1890_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2046-4053-1-10","volume":"1","author":"S Khangura","year":"2012","unstructured":"Khangura S, Konnyu K, Cushman R, et al. Evidence summaries: the evolution of a rapid review approach. Syst Rev. 2012;1:10.","journal-title":"Syst Rev"},{"key":"1890_CR48","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"1890_CR49","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/sim.1875","volume":"23","author":"G Lu","year":"2004","unstructured":"Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105\u201324.","journal-title":"Stat Med"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-01890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-022-01890-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-01890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T07:19:36Z","timestamp":1666595976000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-022-01890-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1890"],"URL":"https:\/\/doi.org\/10.1186\/s13643-022-01890-y","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the nature of the study (systematic review and NMA), no ethical approval will be required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}